Repligen Corporation - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Repligen Corporation Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Repligen Corporation. The Group's principal activity is to develop novel therapeutics primarily for radiology and neuropsychiatry. It currently sells a line of commercial products based on Protein A, which are used in the production of monoclonal antibodies. The Group manufactures and markets several products based on recombinant forms of Protein A. Its primary customers incorporate its Protein A products into their proprietary monoclonal antibody purification products that they sell directly to the biotechnology and pharmaceutical industry.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report